Latest News and Press Releases
Want to stay updated on the latest news?
-
● An estimated $7.8 million gross Revenue for March 2021, the highest in the history of the company ● This represents an estimated 41.8% increase over February gross Revenue of $5.5 million ● More...
-
AGOURA HILLS, California, Feb. 02, 2021 (GLOBE NEWSWIRE) -- Mateon Therapeutics, Inc. (OTCQB:MATN) (“Mateon”), a leading developer of TGF-β therapeutics for oncology and infectious diseases,...